Publications | Cervo Brain Research Centre

Export 4 results:

Filters: Author is Gagnon, Martin [Clear All Filters]

2020

L. - E. Lorenzo, Godin, A. G., Ferrini, F., Bachand, K., Plasencia-Fernandez, I., Labrecque, S., Girard, A. A., Boudreau, D., Kianicka, I., Gagnon, M., Doyon, N., Ribeiro-da-Silva, A., and De Koninck, Y., “Enhancing neuronal chloride extrusion rescues α2/α3 GABA-mediated analgesia in neuropathic pain.”, Nat Commun, vol. 11, no. 1, p. 869, 2020.

2017

M. Gagnon, Bergeron, M. J., Perez-Sanchez, J., Plasencia-Fernandez, I., Lorenzo, L. - E., Godin, A. G., Castonguay, A., Bonin, R. P., and De Koninck, Y., “Reply to The small molecule CLP257 does not modify activity of the K-Cl co-transporter KCC2 but does potentiate GABA receptor activity.”, Nat Med, vol. 23, no. 12, pp. 1396-1398, 2017.

2013

M. Gagnon, Bergeron, M. J., Lavertu, G., Castonguay, A., Tripathy, S., Bonin, R. P., Perez-Sanchez, J., Boudreau, D., Wang, B., Dumas, L., Valade, I., Bachand, K., Jacob-Wagner, M., Tardif, C., Kianicka, I., Isenring, P., Attardo, G., Coull, J. A. M., and De Koninck, Y., “Chloride extrusion enhancers as novel therapeutics for neurological diseases.”, Nat Med, vol. 19, no. 11, pp. 1524-8, 2013.

N. Doyon, Ferrini, F., Gagnon, M., and De Koninck, Y., “Treating pathological pain: is KCC2 the key to the gate?”, Expert Rev Neurother, vol. 13, no. 5, pp. 469-71, 2013.

Funding / Support / Partners

© Gouvernement du Québec